Key result
DiscoVari maps pathogenic variants to hotspots ~2.4-fold more frequently than benign variants.
Why the study?
Incidentally identified cardiac disease-associated gene variants carrying sudden cardiac death risk are increasing, highlighting the need for accurate diagnostic interpretation.
Does amino acid-level signal-to-noise analysis using DiscoVari improve the prediction of variant pathogenicity in cardiomyopathy- and channelopathy-associated genes?
Does amino acid-level signal-to-noise analysis using DiscoVari improve the prediction of variant pathogenicity in cardiomyopathy- and channelopathy-associated genes?
DiscoVari reliably identifies disease-susceptible amino acid hotspots in cardiovascular genes, offering a useful tool to help clarify the diagnostic weight of variants of uncertain significance.
Answers are grounded in this paper and cite their sources.
May aid VUS reclassification in SCD genes; leaves open prospective validation before clinical use.
BACKGROUND: With genetic testing advancements, the burden of incidentally identified cardiac disease-associated gene variants is rising. These variants may carry a risk of sudden cardiac death, highlighting the need for accurate diagnostic interpretation. We sought to identify pathogenic hotspots in sudden cardiac death-associated genes using amino acid-level signal-to-noise (S:N) analysis and develop a web-based precision medicine tool, DiscoVari , to improve variant evaluation. METHODS: The minor allele frequency of putatively pathogenic variants was derived from cohort-based cardiomyopathy and channelopathy studies in the literature. We normalized disease-associated minor allele frequencies to rare variants in an ostensibly healthy population (Genome Aggregation Database) to calculate amino acid-level S:N. Amino acids with S:N above the gene-specific threshold were defined as hotspots. DiscoVari was built using JavaScript ES6 and using open-source JavaScript library ReactJS, web development framework Next.js, and JavaScript runtime NodeJS. We validated the ability of DiscoVari to identify pathogenic variants using variants from ClinVar and individuals clinically evaluated at the Duke University Hospitals with cardiac genetic testing. RESULTS: We developed DiscoVari as an internet-based tool for S:N-based variant hotspots. Upon validation, a higher proportion of ClinVar likely pathogenic/pathogenic variants localized to DiscoVari hotspots (43.1%) than likely benign/benign variants (17.8%; P< 0.0001). Further, 75.3% of ClinVar variants reclassified to likely pathogenic/pathogenic were in hotspots, compared with 41.3% of those reclassified as variants of uncertain significance ( P< 0.0001) and 23.4% of those reclassified as likely benign/benign ( P <0.0001). Of the clinical cohort variants, 73.1% of likely pathogenic/pathogenic were in hotspots, compared with 0.0% of likely benign/benign ( P< 0.01). CONCLUSIONS: DiscoVari reliably identifies disease-susceptible amino acid residues to evaluate variants by searching amino acid-specific S:N ratios.
No takes yet. Share an insight, caveat, or question.
Kurzlechner et al. (2023) studied Cardiomyopathy and channelopathy genetic variants (n=103). DiscoVari (amino acid-level signal-to-noise analysis) vs. Likely benign/benign variants (standard classification) was evaluated on Localization of ClinVar likely pathogenic/pathogenic variants to DiscoVari hotspots compared to likely benign/benign variants (p=<0.0001). The DiscoVari tool identified that a higher proportion of ClinVar likely pathogenic/pathogenic variants localized to amino acid hotspots compared to likely benign/benign variants.
Synapse has enriched 10 related papers. Consider them for comparative context: